AVO announces additional fundraise

Proton beam therapy specialist Advanced Oncotherapy (AVO) has announced a £1.5m equity fundraise to support its operations and provide working capital. The fundraise, which comes on top of £6m raised in October, has been conducted via a direct subscription for a total of 6,000,000  new ordinary shares of 25 pence each by one of its existing institutional shareholders….

You must be a HM Subscriber to view this content.

Subscribe Now »